(64%) remained hyperthyroid (Hper) between ST and LT and 9(25%) hypo or euthyroid (Hpo/Eu) between ST and LT; only 4 (11%) changed from Hper at ST to Hpo/Eu at LT. Thus, 89% did not mdU=y their thyroid flvlction between ST and LT. The period of the evolution f r m Hper to Hpo/Eu showed two distinct populations,one with a X f SD of 17.3 f 3.8 months and another with X f SD of 9.4 f 2.5 y. It is concluded that emhationof thyroid flvlction at ST is usefbl to pdict their status at LT since 9% of patients showed no variations. Since patients who changed thyroid fbcicn from Hper to Hpo/Eu at ST did it in X 17.3 months it is advisable to wait up to this time to select another therapeutic options. If Hper persists the possibility of I 131 administration should be considered to avoid the excessively long treatment required by the unrelenting course of this disease. A l U n & m~t c i i f f e -i n t h ?~~i c n e f f~c t~ r n t e d t e t e m t o t h~t e r c q s m~d R R 1 c p I B l t m m fkpmtly sem after S.C. n r e m adr' ' ' " . All ptjfnts imEa333
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